Recent pharmacological approaches for the treatment of renal cell carcinoma.

Alimohammadi, Arman; Fajkovic, Harun; Remzi, Mesut; Shariat, Shahrokh; Schmidinger, Manuela

Alimohammadi, Arman; Fajkovic, Harun; Remzi, Mesut; Shariat, Shahrokh; Schmidinger, Manuela.

Afiliação

Alimohammadi A; Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria.
Fajkovic H; Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria.
Remzi M; Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria.
Shariat S; Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria.
Schmidinger M; Department of Urology, Weill Cornell Medical College, New York, New York, USA.

Expert Rev Clin Pharmacol ; 15(2): 187-195, 2022 Feb.

Article em En | MEDLINE | ID: mdl-35285369

Assuntos

Carcinoma de Células Renais; Neoplasias Renais; Axitinibe/uso terapêutico; Carcinoma de Células Renais/tratamento farmacológico; Carcinoma de Células Renais/patologia; Humanos; Ipilimumab/uso terapêutico; Neoplasias Renais/tratamento farmacológico; Neoplasias Renais/patologia; Sunitinibe/uso terapêutico

Palavras-chave

Renal cell carcinoma; immune check point inhibitors; tyrosine kinase inhibitors

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google